Inactive Instrument

Highlights Sinopharm Group Co., Ltd. Shanghai - Hong Kong Stock Connect

Equities

1099

CNE100000FN7

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status	14/05	MT
Wall Street Cues, Property Outlooks Lift Asian Stock Markets	29/04	MT
China, Hong Kong stocks rise, led by property shares	29/04	RE
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit	29/04	DJ
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise	29/04	MT
Central Bank, Tech Outlooks Lift Major Asian Stock Markets	26/04	MT
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets	16/04	MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator	27/03	MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue	25/03	MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024	25/03	CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03	CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03	MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	22/02	MT
Sinopharm offers to take China-TCM private in nearly $3 bln deal	21/02	RE
Shyndec Pharma Unit's Cefotaxime Sodium for Injection Passes Drug Regulator's Consistency Evaluation	21/02	MT
Cancer Drug of Shyndec Pharma's Unit Passes Drug Regulator's Evaluation	20/02	MT
Sinopharm to Renew Financial Services Deal with Affiliate	28/12	MT
Hutchmed China renews deals with "substantial" shareholders	21/12	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sinopharm Group Co., Ltd. Shanghai - Hong Kong Stock Connect

Equities

1099

CNE100000FN7

Highlights

Filters